NCT05822518Completed
Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy
Source: ClinicalTrials.gov · Last updated 26 Mar 2024
Brief summary (registry, in English)
The aim of this study is to evaluate the outcome of perioperative immune-nutrition with glutamine, arginine and fish oil in patients undergoing radical cystectomy as regards to enhancement of healing, increasing immunity and improving overall health status.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 42 (actual)
- First submitted
- 1 Apr 2023
- Start date
- 1 Jun 2022
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Menoufia University
- Diseases
- Bladder cancer, Childhood cancers
- NCT number
- NCT05822518
What you commit to
- Study type: Interventional
- Participants enrolled: 42
- From 1 Jun 2022 to the primary completion date, 30 Nov 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Relevant food allergies.
- Severe renal and hepatic insufficiency.
Other
- Coagulopathy.
- Distant metastasis.
- Body mass index less than 18.5.
Who the study is looking for
- Patients with CT showing bladder mass with radiological staging of T2 or T3.
- Patients pathologically proven to have cancer bladder.
- Patients undergoing radical cystectomy with ileal conduit.
- The American Society of Anesthesiologists Physical Status classification system (ASA PS) of 1, 2 or 3.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Menoufia Faculty of Medicine Coordinator of this site? Confirm its status | Shibīn al Kawm | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.